Trulicity and Adhd - a phase IV clinical study of FDA data

Summary:

Adhd is reported as a side effect among people who take Trulicity (dulaglutide), especially for people who are female, 60+ old, also take Albuterol, and have High blood pressure.

The phase IV clinical study analyzes which people have Adhd when taking Trulicity. It is created by eHealthMe based on reports of 76,923 people who have side effects when taking Trulicity from the FDA, and is updated regularly.

What is Trulicity?

Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,527 Trulicity users. Check the latest studies of Trulicity.

What is Adhd?

Adhd (adhd-mental disorders that develop in children) is found to be associated with 600 drugs and 1,371 conditions by eHealthMe. Check the latest studies of Adhd.

On Nov, 01, 2025

76,923 people reported to have side effects when taking Trulicity.
Among them, 12 people (0.02%) have Adhd.

Among these 12 people:

What is the gender of people who have Adhd when taking Trulicity? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Adhd when taking Trulicity? *

What are other drugs people take besides Trulicity? *

What are other side effects people have besides Adhd? *

Indigestion: 6 people, 50.00%
Depression: 6 people, 50.00%
Muscle Spasms (muscle contraction): 6 people, 50.00%
Pain: 6 people, 50.00%
Nausea And Vomiting: 6 people, 50.00%
Nausea (feeling of having an urge to vomit): 6 people, 50.00%
Cholestatic Liver Injury (due to injury bile cannot floe from liver): 5 people, 41.67%
Histamine Level Increased: 5 people, 41.67%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 5 people, 41.67%
Acute Kidney Failure: 5 people, 41.67%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 50.00%
Lung Disorder (lung disease): 5 people, 41.67%
Sinusitis (inflammation of sinus): 5 people, 41.67%
Asthma: 5 people, 41.67%
Upper-Airway Cough Syndrome: 4 people, 33.33%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 4 people, 33.33%
Eye Discharge: 4 people, 33.33%
Abdominal Discomfort: 4 people, 33.33%
Pain: 4 people, 33.33%
Secretion Discharge: 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Trulicity and have Adhd?

- Check whether Adhd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trulicity:

Trulicity (77,527 reports)

Adhd treatments and more:

Adhd (120,225 reports)

Browse all side effects of Trulicity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adhd:

Adhd (600 drugs)

Browse all the conditions that are associated with Adhd:

Adhd (1,371 conditions)

Drugs similar to Trulicity and Adhd :

Related publications that referenced our studies

Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dulaglutide (the active ingredients of Trulicity) and Trulicity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.